Literature DB >> 19319009

Orientation discrimination with macular changes associated with early AMD.

Harold E Bedell1, Jianliang Tong, Stanley Y Woo, Jon R House, Tammy Nguyen.   

Abstract

PURPOSE: Age-related macular degeneration (AMD) is a condition that progressively reduces central vision in elderly individuals, resulting in a reduced capacity to perform many daily activities and a diminished quality of life. Recent studies identified clinical treatments that can slow or reverse the progression of exudative (wet) AMD and ongoing research is evaluating earlier interventions. Because early diagnosis is critical for an optimal outcome, the goal of this study is to assess psychophysical orientation discrimination for randomly positioned short line segments as a potential indicator of subtle macular changes in eyes with early AMD.
METHODS: Orientation discrimination was measured in a sample of 74 eyes of patients aged 47 to 82 years old, none of which had intermediate or advanced AMD. Amsler-grid testing was performed as well. A masked examiner graded each eye as level 0, 1, 2, or 3 on a streamlined version of the Age-Related Eye Disease Study (AREDS) scale for AMD, based on the presence and extent of macular drusen or retinal pigment epithelium (RPE) changes. Visual acuity in the 74 eyes ranged from 20/15 to 20/40, with no significant differences among the grading levels. Humphrey 10-2 and Nidek MP-1 micro-perimetry were used to assess retinal sensitivity at test locations 1 degrees from the locus of fixation.
RESULTS: Average orientation-discrimination thresholds increased systematically from 7.4 degrees to 11.3 degrees according to the level of macular changes. In contrast, only 3 of 74 eyes exhibited abnormalities on the Amsler grid and central-field perimetric defects occurred with approximately equal probability at all grading levels.
CONCLUSIONS: In contrast to Amsler grid and central-visual-field testing, psychophysical orientation discrimination has the capability to distinguish between eyes with and without subtle age-related macular changes.

Entities:  

Mesh:

Year:  2009        PMID: 19319009      PMCID: PMC2837926          DOI: 10.1097/OPX.0b013e31819fa6e2

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  32 in total

1.  Orientation discrimination in foveal and extra-foveal vision: effects of stimulus bandwidth and contrast.

Authors:  Sharon L Sally; Rick Gurnsey
Journal:  Vision Res       Date:  2003-06       Impact factor: 1.886

2.  Quantification of metamorphopsia in patients with epiretinal membranes.

Authors:  Chota Matsumoto; Eiko Arimura; Sachiko Okuyama; Sonoko Takada; Shigeki Hashimoto; Yoshikazu Shimomura
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

3.  Filling-in of retinal scotomas.

Authors:  Dror Zur; Shimon Ullman
Journal:  Vision Res       Date:  2003-04       Impact factor: 1.886

4.  Shape discrimination in age-related macular degeneration.

Authors:  Yi-Zhong Wang; Elaine Wilson; Kirsten G Locke; Albert O Edwards
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

5.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-10

6.  Modelling of orientation discrimination across the visual field.

Authors:  P Mäkelä; D Whitaker; J Rovamo
Journal:  Vision Res       Date:  1993 Mar-Apr       Impact factor: 1.886

7.  Prevalence of age-related macular degeneration in the United States.

Authors:  David S Friedman; Benita J O'Colmain; Beatriz Muñoz; Sandra C Tomany; Cathy McCarty; Paulus T V M de Jong; Barbara Nemesure; Paul Mitchell; John Kempen
Journal:  Arch Ophthalmol       Date:  2004-04

8.  Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study.

Authors:  Rohit Varma; Samantha Fraser-Bell; Sylvia Tan; Ronald Klein; Stanley P Azen
Journal:  Ophthalmology       Date:  2004-07       Impact factor: 12.079

9.  Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.

Authors:  Sandra C Tomany; Jie Jin Wang; Redmer Van Leeuwen; Ronald Klein; Paul Mitchell; Johannes R Vingerling; Barbara E K Klein; Wayne Smith; Paulus T V M De Jong
Journal:  Ophthalmology       Date:  2004-07       Impact factor: 12.079

10.  Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration.

Authors:  Anat Loewenstein; Rafael Malach; Michaela Goldstein; Igal Leibovitch; Adiel Barak; Eli Baruch; Yair Alster; Omer Rafaeli; Isaac Avni; Yuval Yassur
Journal:  Ophthalmology       Date:  2003-05       Impact factor: 12.079

View more
  5 in total

1.  Early age-related macular degeneration impairs tolerance to stimulus degradation.

Authors:  Lei Liu; Janis White
Journal:  Optom Vis Sci       Date:  2010-08       Impact factor: 1.973

2.  Simulated loss of foveal vision eliminates visual search advantage in repeated displays.

Authors:  Franziska Geringswald; Florian Baumgartner; Stefan Pollmann
Journal:  Front Hum Neurosci       Date:  2012-05-11       Impact factor: 3.169

3.  Relationships of orientation discrimination threshold and visual acuity with macular lesions in age-related macular degeneration.

Authors:  Haojie Fu; Bin Zhang; Jianliang Tong; Harold Bedell; Hecheng Zhang; Yating Yang; Chaochao Nie; Yingdong Luo; Xiaoling Liu
Journal:  PLoS One       Date:  2017-09-18       Impact factor: 3.240

Review 4.  Should clinical automated perimetry be considered for routine functional assessment of early/intermediate age-related macular degeneration (AMD)? A systematic review of current literature.

Authors:  Matt Trinh; Michael Kalloniatis; Lisa Nivison-Smith
Journal:  Ophthalmic Physiol Opt       Date:  2021-11-29       Impact factor: 3.992

5.  Simple Vision Function Tests that Distinguish Eyes with Early to Intermediate Age-related Macular Degeneration.

Authors:  Lori A Lott; Marilyn E Schneck; Gunilla Haegerstrom-Portnoy; Susan Hewlett; Natalie Stepien-Bernabe; Bonnie M Gauer; Ali Zaidi; Arthur D Fu; John A Brabyn
Journal:  Ophthalmic Epidemiol       Date:  2020-08-12       Impact factor: 1.648

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.